Erin Hughes
About Erin Hughes
Erin Hughes is the Associate Director, Program Lead at Bristol Myers Squibb in Seattle, Washington, with extensive experience in clinical data management and a strong background in environmental and occupational health sciences.
Associate Director, Program Lead at Bristol Myers Squibb
Erin Hughes currently serves as the Associate Director, Program Lead at Bristol Myers Squibb in Seattle, Washington. She has been with the company since 2020 and has been integral to driving clinical data management programs and initiatives. Her role includes overseeing the implementation of Good Clinical Data Management Practices (GCDMP) and managing multiple priorities and stakeholders effectively.
Career at ICON plc
Before joining Bristol Myers Squibb, Erin Hughes worked at ICON plc for three years. She started as a Clinical Data Lead in 2017 and quickly advanced to Senior Clinical Data Lead and then to Project Manager, Data Management. Throughout her time at ICON plc, she gained extensive experience with electronic data capture (EDC) systems, specifically Medidata and DatStat Illume, and conducted both domestic and international clinical trial trainings.
Previous Roles at Fred Hutch and University of Washington
Erin Hughes has also held significant roles at Fred Hutch and the University of Washington. At Fred Hutch, she worked as a Clinical Data Manager and Project Coordinator from 2011 to 2017, handling various clinical data management tasks. At the University of Washington, her roles ranged from Research Scientist / Program Coordinator to Teaching Assistant, contributing to research in environmental and occupational health sciences.
Educational Background
Erin Hughes has an extensive educational background. She earned a Master of Public Health (MPH) in Environmental and Occupational Health Sciences from the University of Washington. She also completed interdisciplinary studies at the University of Cape Town and achieved a Bachelor of Arts (BA) in Neuroscience with a minor in Kinesiology from the University of Southern California. Her academic experience has provided a strong foundation in the science, research ethics, and design of clinical trials.